◆ 会议时间：2024年5月25-28日
◆ 会议地点：土耳其 伊斯坦布尔
◆ 会议简介：
2024年第72届欧洲心血管和腔内血管外科学会(ESCVS)年会将于2024年5月25日至28日在土耳其伊斯坦布尔举行。ESCVS大会是血管外科及介入治疗领域的国际盛会之一，每年都有来自全球50多个国家的近4000名心血管外科及腔内血管外科专业人士参会。
欧洲心血管和腔内血管外科学会(ESCVS)成立于1951年，是欧洲历史最悠久的心血管外科学会，致力于通过教育、基础科学与临床研究，宣促进心血管疾病的科学与治疗。 未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）
72nd Congress of the European Society of Cardiovascular and Endovascular Surgery (ESCVS2023)
Date: 25 to 28 May 2024
Venue：Istanbul, Turkey
摘要征文投稿：
CALL FOR ABSTRACTS
- Abstract Submission System Opens: Sep 1st,2023
- Abstract Submission Deadline: Mar 4th, 2023
- Notification of acceptance or rejection: Mar 14th, 2023
- PDF of posters and MP4 recordings due: May 10th, 2023
点此提交摘要>>>Submit Abstract>>
SUBMISSION INFORMATION
Individuals may submit an unlimited number of abstracts, each up to 300 words
All submitted abstracts will undergo a blinded peer review and are assessed for quality of research, educational or scientific content, logical presentation, and impact on healthcare
The top tier selected abstracts will be integrated in the scientific programme as oral presentations
Abstracts not selected for oral presentations will be displayed onsite as poster presentations
Authors will be given the opportunity to record a 3’ presentation to be displayed on the digital platform (to be prepared in a MP4 format)
Confirmed poster presenters must register to attend
Authors/ submitters agree to upload the abstract as a poster if it is selected for inclusion at the ESCVS annual meeting onsite or on the virtual platform
ABSTRACTS TOPICS
CARDIAC
Adult Congenital
AF and CABG
Anesthesia Techniques and New Developments
AnOPCAB (Anaortic Techniques)
Aortic Valve and Aortic Root Surgery
Atrioventricular Valve (Mitral/Tricuspid) Surgery
Bypass Grafts and Configurations
Challenging Cases
Complex Congenital Heart Disease
Coronary Artery Bypass in Women
Diffuse Coronary Disease and Endarterectomy
ERAS and New Techniques and Technologies
Harvesting Techniques
Ischemic Mitral Regurgitation
Left Ventricular Outflow Tract Obstruction
Management of Reoperations
MICAB (Minimally Invasive Coronary Artery Bypass) (Including MIDCAB, MICS-CABG, TCRAT, LAST, MACAB)
Off-pump CABG
On-pump CABG
Pulmonary Valve Intervention
Quality Control and Graft Patency
Robotic Techniques
Role of Heart Team
Total Arterial Revascularization |
VASCULAR AND ENDOVASCULAR
Abdominal Aorta
AV Access
Carotid Disease
Miscellaneous
PAOD
Prosthetic Infections
Thoracic Aorta
Venous
Visceral
|
INTERDISCIPLINARY
Aortic dissection & Surgical Treatment (Open and Endovascular)
Aortic Valve
Arrhythmia Surgery
Catheter-based Valve Procedures
Clinical Trials / Guidelines / Registries
Comparison of Surgical Versus Catheter Procedures and Complications
ESC WG Cardiovascular Surgery
ESC-ESCVS: Gaps in the Guidelines
Heart Failure
Heart Transplant and Circulatory Support
Infective Endocarditis
Intensive Care
MCS / ECLS / ECMO
Miscellaneous
Mitral Valve
Multivalve Disease
Tricuspid Valve |
Dear Colleagues,
We are pleased to invite you to the 72nd Congress of the ESCVS, the European Society of Cardiovascular and EndoVascular Surgery, which will be held in İstanbul, Turkey, from 25 to 28 May 2024.
I would like to express my great happiness that our community, which has existed since 1951, will meet for the 72nd time in Istanbul, which has hosted two of the past 71 congresses, to share the latest information and developments.
72nd Congress of the ESCVS is the premier meeting for cardiovascular and endovascular surgeons from around the world. Cardiovascular diseases are the leading cause of death worldwide, and it is our responsibility as researchers to work towards finding solutions to this global health challenge. I encourage you all to take advantage of this opportunity to connect with your colleagues, share your knowledge and expertise, and engage in meaningful discussions that will help us advance our understanding of cardiovascular diseases .
This year's congress will feature a comprehensive program of scientific sessions, including keynote lectures, symposia, workshops, hybrid sessions and poster presentations. The program will cover a wide range of topics.
I addition to the scientific program, the ESCVS Congress will also offer a variety of social activities, including a welcome reception, gala dinner, and excursions In the charming atmosphere of Istanbul.
Istanbul is a unique city with its major role in history as the capital of three succesive empires. As the only city in the world situated on two continents -Asia and Europe- İstanbul has proved an attractive settlement for various civilizations since ancient times. Thanks to its rich history, colorful daily life and dynamic spirit, İstanbul continues to offer a once in a lifetime experience to its visitors.
I hope you will join us in Istanbul for the 72nd Congress of the ESCVS. It promises to be an exciting and informative Congress.
We look forward to seeing you in beautiful Istanbul!
Sincerely,
Prof. Dr. Ergun Demirsoy
President of the Congress
注册费：
| Registration |
Early Bird Until March 15, 2024 |
Regular Until April 30, 2024 |
Late and Onsite From May 01, 2024 |
| ESCVS Member |
350,00 € |
450,00 € |
550,00 € |
| Non ESCVS Member |
450,00 € |
550,00 € |
650,00 € |
| Nurse / Perfusionist* |
150,00 € |
200,00 € |
250,00 € |
| Junior ESCVS Members** |
150,00 € |
200,00 € |
250,00 € |
| Junior non ESCVS Members** |
200,00 € |
250,00 € |
300,00 € |
| Partner Company Representative*** |
280,00 € |
330,00 € |
380,00 € |
| Non Partner Company Representative |
1.000,00 € |
1.200,00 € |
1.400,00 € |
| Gala Dinner Ticket |
85,00 € |
85,00 € |
85,00 € |
| VAT of 20% included |
*Nurse / Perfusionist: please send proof of your status to registration@escvs2024.com
** Junior/non member (<35 years old)
** Please send recommendation letter from your programme director to secretariat@escvs2024.com
*** Company representatives do not have access to scientific sessions
Registration fees include: Welcome Cocktail, Lunches, Coffee Breaks, access to the scientific sessions, the industry exhibits and the congress documents (Program, Certificate of Attendance, Congress Badge)
◆ 参会对象：医生、药剂师、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
